THE POSSIBILITY OF APPLYING FLURBIPROFEN IN PATIENTS WITH LUMBAR PAIN

Abstract

Lumbar pain (LP) is the most common form of musculoskeletal pain syndromes, the development of which is associated with significant financial costs. Treatment of LP patients is usually long-term, which increases the risk of undesirable side effects. The pharmacological effects of Flurbiprofen for treating patients with PB are considered.

Keywords

lumbar pain / treatment / safety / flurbiprofen

References

[1] Гусев Е.И., Никифоров А.С., Камчатнов П.Р. Неврологические симптомы, синдромы и болезни. 2-е издание. М.: Гэотар-Медиа, 2014. 1040 с.

[2] Akimoto H., Yamazaki R., Hashimoto S. et al. Four hydroxy aceclofenac suppresses the interleukin 1 induced production of promatrix metalloproteinases and release of sulfatedglycosaminoglycans from rabbit articular chondrocytes // European Journal of Pharmacol. 2000. Vol. 401. P. 429-436.

[3] Calvo E., Palacios I., Delgado E. et al. Histopathological correlation of cartilage swelling detected by magnetic resonance imaging in early experimental osteoarthritis // Osteoarthritis and Cartilage. 2004. Vol. 12, № 11. Р. 878-86.

[4] CDC. National Ambulatory Medical Care Survey: 2010 Summary Tables. Table 9. www.cdc.gov/nchs/data/ahcd/namcs_summary/2010_namcs_ web_tables.pdf. Accessed March 29, 2016.

[5] Dedrick D., Goldstein S., Brandt K. et al. A longitudinal study of subchondral plate and trabecular bone in cruciate-deficient dogs with osteoarthritis followed up for 54 months // Arthritis and Rheumatology. 1993.Vol. 36, № 10. Р. 1460-1467.

[6] Dionne R., Snyder J., Hargreaves K.M. Analgesic Efficacy of Flurbiprofen in Comparison With Acetaminophen, Acetaminophen Plus Codeine, and Placebo After Impacted Third Molar Removal // Journal of Oral and Maxillofacial Surgery. 1994. Vol. 52, P. 919-924.

[7] Fujii Y., Itakura M. Comparison of Lidocaine, Metoclopramide, and Flurbiprofen Axetil for Reducing Pain on Injection of Propofol in Japanese Adult Surgical Patients: A Prospective, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study // Clinical Therapeutics. 2008. Vol. 30, №2. P. 280-206.

[8] Gjesdal S., Holmaas T., Monstad K., Hetkevik O. New episodes of musculoskeletal conditions among employed people in Norway, sickness sertification and return to work: a multi-registered cohort study from primary care // BMJ. 2018. Vol. 8, №3. Р. 34-40.

[9] Guven Z., Ofluoglu D., Ozaras N., Kayhan O. Kronik bel agrisinda flurbiprofenin etkinligi: placebo kontrollu cift kor calisma // Romatizma. 2000. Vol. 2, № 15. P. 161-165.

[10] Hoy D., March L., Brooks P. et al. The global burden of low back pain: estimates from the Global Burden of Disease 2010 study // Annales of Rheumatic Diseases. 2014. Vol.73. P. 968-974.

[11] Huang S., Cao X., LiJ., Han Y. Analgesic effect of flurbiprofen axetil in treatment of single hole thoracoscopic surgery for pneumothorax // Pakistan Journal of Pharmacological Science. 2017. Vol. 30, № 5. P. 1875-1882.

[12] Jonhson A.G., Nguyen T.V., Day R.O. Do nonsteroidal anti-inflammatory drugs on affect blood pressure? A meta-analysis // Annales of Internal Medicine. 1994. Vol. 121, № 4. Р. 289-300.

[13] Katz. J. Lumbar disc disorders and low-back pain: socioeconomic factors and consequences // Journal of Bone and Joint Surgery of America. 2006. № 88(2). Р. 21-28.

[14] Karvonen R., Miller P., Nelson D. et al. Periarticular osteoporosis in osteoarthritis of the knee // J Rheumatol. 1998. Vol.25, №11. Р. 2187-2194.

[15] Luo X., Luv F., Peng М. Analgesic effect of different dosage of Flurbiprofen axetil in laparoscopic cholecystectomy in comparison with other analgesic drugs // Pakistan Journal of Pharmacological Science. 2017. Vol. 30, №5. Р. 1895-1898.

[16] Mafi J., McCarthy E., Davis R., Landon B.Worsening Trends in the Management and Treatment of Back Pain // JAMA Interational Medicine. 2013. Vol. 173, №17. P. 1573-1581.

[17] Montgomery W., Sato M., Nagasaka Y., Vietri J. The economic and humanistic costs of chronic lower back pain in Japan // ClinicoEconomics and Outcomes Research. 2017. № 9. P. 361-371.

[18] Nordeman L., Thorselius L., Gunnarsson R., Mannerkorpi K. Predictors for future activity limitation in women with chronic low back pain consulting primary care: a 2-year prospective longitudinal cohort study // BMJ Open. 2017. Vol. 7:e013974.

[19] Panico A.M., Cardile V., Vittorio F. et al. Different in vitro activity of flurbiprofen and its enantiomers on human articular cartilage // Il Farmacology. 2003. Vol. 58. P. 1339-1344.

[20] Park P., Dryer R., Hegeman-Dingle R. et al. Cost Burden of Chronic Pain Patients in a Large Integrated Delivery System in the United States. // Pain Practice. 2016. Vol. 16, №8. Р. 1001-1011.

[21] Permuy M., Guede D., López-Peña M. et al. Comparison of various SYSADOA for the osteoarthritis treatment: an experimental study in rabbits // BMC Musculoskeletal Disorders. 2015. Vol. 16. P.120-126.

[22] Salari P., Abdollahi M. Controversial effects of non-steroidal ayni-inflammatory drugs on bone: a review // Inflammation and Allergy. Drug Targets. 2009. Vol.8. P. 165-175.

[23] Siegmett W., Noyelle R. Night pain and morning stiffness in osteoartritis: a crossover study of diclofenac and flurbiprofen // Journal of Internal Medicine Research. 1988. Vol. 16. P. 182-188.

[24] Sivasubramaniam V., Patel H., Ozdemir B. Trends in hospital admissions and surgical procedures for degenerative lumbar spine disease in England: a 15-year time series study // BMJ Open. 2015. Vol. 5: e009011.

[25] Wang K., Luo J., Zheng L., Luo T. Preoperative flurbiprofen axetil administration for acute postoperative pain: a meta-analysis of randomized controlled trials // Journal of Anesthesiology. 2016. Vol. 31, № 6. P. 852-860.

[26] Zhao X., Ji L. Flurbiprofen axetil: Analgesic effect and adverse reaction // Pakistan Journal of Pharmacological Science. 2018. Vol. 31, №3. Р. 1163-1167.

RIGHTS & PERMISSIONS

Kamchatnov P.R., Chugunov A.V., Kazakov A.Y.